INMUNE BIO INC. Cash
INMUNE BIO INC. (INMB) had Cash of $21.97 million as of 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Balance Sheet › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2022-03-03
- 2020-12-31: Cash $21.97M.
- 2020-09-30: Cash $24.31M.
- 2020-06-30: Cash $4.82M.
- 2020-03-31: Cash $5.93M.
| Period end | Cash |
|---|---|
| 2020-12-31 | $21.97M 10-K · filed 2021-03-04 |
| 2020-09-30 | $24.31M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.82M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $5.93M 10-Q · filed 2020-05-14 |
| 2020-01-31 | $1.01M 10-K · filed 2022-03-03 |
| 2019-12-31 | $7.00M 10-K · filed 2021-03-04 |
| 2018-12-31 | $186.20K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |